EMERGENT BIOSOLUTIONS INC. Deferred Revenue (Non-Current)
EMERGENT BIOSOLUTIONS INC. (EBS) had Deferred Revenue (Non-Current) of $17.26 million as of 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-02-23
- 2017-12-31: Deferred Revenue, Noncurrent $17.26M.
- 2017-09-30: Deferred Revenue, Noncurrent $24.97M.
- 2017-06-30: Deferred Revenue, Noncurrent $17.09M.
- 2017-03-31: Deferred Revenue, Noncurrent $13.89M.
| Period end | Deferred Revenue, Noncurrent | Deferred Revenue, Noncurrent as first filed |
|---|---|---|
| 2017-12-31 | $17.26M 10-K · filed 2018-02-23 | |
| 2017-09-30 | $24.97M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $17.09M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $13.89M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $8.43M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $4.70M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $8.41M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $6.82M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $3.43M 10-K · filed 2017-02-28 | $6.59M 10-K · filed 2016-02-29 |
| 2015-09-30 | $5.99M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $6.08M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.81M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $5.71M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $5.82M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.63M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.80M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-09 | |
| 2011-12-31 | $0.00 10-K · filed 2012-03-09 | |
| 2011-09-30 | $2.78M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $2.95M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $4.39M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |